Lumos Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Lumos Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 35% to $2,051,000. Profit margin reached -1659%. Total operating expenses were $38,665,000.
Profit Margin
| 2014 | 165.95M | 102.85M | 61.98% |
|---|---|---|---|
| 2015 | 36.14M | -40.38M | -111.73% |
| 2016 | 3.52M | -85.15M | -2415.06% |
| 2017 | 390K | -71.95M | -18448.97% |
| 2018 | 1.20M | -53.59M | -4444.03% |
| 2019 | 936K | -42.98M | -4592.84% |
| 2020 | 168K | -5.66M | -3370.83% |
| 2021 | 230K | -30.43M | -13230.43% |
| 2022 | 1.52M | -31.06M | -2039.53% |
| 2023 | 2.05M | -34.03M | -1659.39% |
LUMO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 2.05M | 1.52M | 230K | 168K | 936K | 1.20M | 390K | 3.52M | 36.14M | 165.95M |
Cost of revenue | 0 | 49K | 0 | 0 | 37K | -11.26M | 1.40M | 0 | -32.35M | -6.64M |
Gross profit | 2.05M | 1.47M | 230K | 168K | 899K | 12.47M | -1.01M | 3.52M | 68.50M | 172.59M |
Operating exp. | ||||||||||
Research and development | 22.09M | 17.85M | 16.24M | 9.20M | 22.20M | 45.69M | 69.86M | 93.3M | 71.41M | 35.69M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 38.66M | 33.56M | 31.57M | 26.47M | 46.07M | 63.64M | 73.27M | 94.28M | 69.74M | 48.37M |
Operating income | -36.61M | -32.04M | -31.34M | -26.30M | -45.13M | -62.43M | -72.88M | -90.75M | -33.60M | 117.57M |
Other income (expenses), net | 2.55M | 965K | 281K | 6.66M | 2.15M | -102K | 371K | 247K | -41K | 60K |
Income before tax | -34.06M | -31.07M | -31.06M | -19.63M | -42.97M | -60.56M | -72.51M | -90.51M | -33.64M | 117.63M |
Income tax expense | -29K | -13K | -636K | -13.97M | 12K | -6.96M | -559K | -5.35M | 6.73M | 14.77M |
Net income | -34.03M | -31.06M | -30.43M | -5.66M | -42.98M | -53.59M | -71.95M | -85.15M | -40.38M | 102.85M |
Earnings per share | ||||||||||
Basic EPS | -4.18 | -3.71 | -3.65 | -0.84 | -297.07 | -12.97 | -20.69 | -26.45 | -12.71 | 31.05 |
Diluted EPS | -4.18 | -3.71 | -3.65 | -0.84 | -297.07 | -12.97 | -20.69 | -26.45 | -12.71 | 27.81 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |